Judge Eric C. Tostrud tossed or trimmed many of the racketeering and antitrust claims brought by wholesalers in the U.S. District Court for the District of Minnesota over the alleged scheme to inflate the EpiPen’s price through bribes and kickbacks aimed at marginalizing a competing device.
The case is one of two consolidated lawsuits that targeted Mylan and the country’s top ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.